Evidence map›Paper›PMID 9201723›Full record

ArticleMolecular biology of the cell1997

Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association.

A Wolven, H Okamura, Y Rosenblatt, M D Resh

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 163 citations in OpenAlex.

  1. Review
  2. Context-dependent roles of palmitoylation in acute respiratory distress syndrome: integrating inflammation, cell death and repair.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. ProteinOpen biology · 2021
    Review
  7. Review
  8. Nature cancer · 2021
    Article
  9. Article
  10. Article
  11. Protein Palmitoylation in Leukocyte Signaling and Function.Frontiers in cell and developmental biology · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Engineered kinase activation reveals unique morphodynamic phenotypes and associated trafficking for Src family isoforms.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A WolvenProgram in Molecular Biology, Cornell University Graduate School of Medical Sciences, New York, New York 10021, USA.
H Okamura
Y Rosenblatt
M D Resh
Cornell University · US

Funding

VASCULAR BIOCHEMISTRY AND ATHEROSCLEROSIST32HL007423 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HAJJAR, KATHERINE AMBERSON · 1985 to 2009
$2.4M
NHLBI NIH HHS T32 HL-07423
6 · The paper itself

Abstract

Members of the Src family of protein tyrosine kinases are localized to subspecialized regions of the plasma membrane. Herein we show that the N-terminal SH4 region of the Src family member p59fyn (Fyn) is both necessary and sufficient for targeting of Fyn and heterologous proteins to the plasma membrane and detergent-insoluble subdomains. Attachment of the first 16 amino acids of Fyn to a normally cytosolic protein, beta-galactosidase, resulted in distinct plasma membrane localization of the chimeric protein. Mutation of the palmitoylation site (cysteine-3) within Fyn16-beta-galactosidase or wild-type Fyn abrogated plasma membrane localization, resulting in redistribution of the mutant proteins into intracellular membranes. Substitution of the SH4 motif within Fyn with heterologous sequences from other palmitoylated proteins (G alpha o and GAP43) revealed that the presence of palmitate is sufficient to direct plasma membrane localization independent of surrounding amino acid sequences and myristate. Palmitoylated Fyn chimeras were also enriched in the Triton X-100-resistant matrix, whereas nonpalmitoylated forms of these proteins were detected in the detergent-soluble fraction. The palmitate moiety on Fyn exhibited a half-life of 1.5-2 h. In contrast, the half-life of the polypeptide backbone was 8 h, indicating that palmitoylation is a reversible modification. These studies establish that the palmitoylated SH4 sequence of Fyn can be used to specifically target proteins to the plasma membrane in a reversible manner.

Indexed as

3T3 CellsAmino Acid SequenceAnimalsCell CompartmentationCell MembraneCOS CellsMiceMyristatesOctoxynolPalmitatesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynRecombinant Fusion ProteinsRecombinant ProteinsFyn protein, mouseMyristatesOctoxynolPalmitatesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynRecombinant Fusion ProteinsRecombinant Proteins

Identifiers

PMID9201723
PMCPMC305721
OpenAlexW2106230884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.